Table 2.

Summary of Articles Evaluating Quality of Life in CF‐CRS Patients.

Validated Instrument	Age Group	Reporter	Design	Validated in CF patient population
Sinonasal‐5	2–12	Parent Reported	‐7 point response to 5 symptoms ‐Average score ‐10 Point Visual analogue scale for overall QOL	No
Sinonasal Outcomes Test‐20	≥18	Patient reported	‐20 question CRS related questions ‐0–5 score ‐Average Magnitude score ‐Top 5 ranked by reporter	No
Sinonasal Outcomes Test‐16	≥18	Patient reported	‐4 questions less than SNOT‐20 for research purposes ‐Same scoring as SNOT‐20	No
Sinonsal Outcomes Test‐22	≥18	Patient reported	‐SNOT‐22 with additional questions for nasal obstruction and smell disturbance ‐0–5 score ‐Average magnitude score ‐Top 5 are not ranked	No

CF = cystic fibrosis; CRS = chronic rhinosinusitis; QOL = quality of life; SNOT‐20 = sinonasal outcome test‐20; SNOT‐22 = sinonasal outcomes test‐22.